◆ TICKERBASE · US STOCK FINANCIAL DATA LIBRARY

HomeAll stocksPFE › Shares Outstanding

Pfizer Inc (PFE) Shares Outstanding 2006–TTM

DATA UPDATED 2026-07-12

Pfizer Inc annual shares outstanding for fiscal TTM was 5,731 million shares, an increase of 0.8% from 5,686 million shares in fiscal 2025. All figures are reported results from public filings — no estimates or projections.

PFE Annual Shares Outstanding

Shares Outstanding (annual)TTM → 2026-03-312025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-31
Shares Outstanding (M)5,731M5,686M5,700M5,709M5,733M5,708M5,632M5,675M5,977M1,212M1,232M1,251M1,285M6,895M7,508M7,870M8,074M7,045M6,750M6,939M7,274M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

PFE Quarterly Shares Outstanding

Shares Outstanding (quarterly)2026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-30
Shares Outstanding (M)5,731M5,686M5,714M5,706M5,710M5,703M5,705M5,696M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

More PFE metrics: Revenue · Gross Profit · Operating Income · Net Income · EPS · EBITDA · Free Cash Flow

All PFE financial statements → Interactive PFE charts →

About TickerBase · Data methodology & sources

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.